Never heard of KOSEC but most brokers/funds don't know what to expect with US earnings. I think the fact most of management bought more at under $1 shows the confidence they have.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025